Chronic Cold Exposure and Energy Metabolism in Humans
Impact of Chronic Cold Exposure on Energy Metabolism in Humans
2 other identifiers
observational
7
1 country
1
Brief Summary
Background: \- Researchers are studying how metabolism and hormone levels change in response to mild changes in environmental temperature. Changes in metabolism may lessen with time because of hormonal adaptations. If this increase in metabolism continues for a longer period, mild cold exposure may cause weight loss. It is unclear whether exposure to a warmer temperature may cause opposite changes in metabolism. Researchers want to see if longer exposure (1 month) to different temperatures can affect how the body uses energy. Objectives: \- To test changes in energy metabolism in response to different room temperatures. Eligibility: \- Healthy men between 18 and 40 years of age. Design:
- The entire study will last for 4 months. It will involve a screening visit and a 4-month inpatient stay at the National Institutes of Health Clinical Center. The inpatient stay will be in a private room at the Metabolic Clinical Research unit. Study participants will be required to stay in the Metabolic Clinical Research unit during the night, but are free to leave during the day.
- At the screening visit, participants will have a physical exam and medical history. Blood samples will be collected. A heart function test and diet questionnaire will also be given.
- During the first month, the temperature of the private room will be set at to 75.2 degrees F. This will allow the body to become used to the testing environment.
- During the second month, the temperature will be set to either a cool (66.2 degrees F) or a warm (80.6 degrees F) temperature.
- During the third month, the temperature will return to 75.2 degrees F.
- During the fourth month, the temperature will be altered to the opposite temperature to the one set in the second month.
- Throughout stay, participants will have daily temperature monitoring and will keep a food diary. Once a week, they will collect all of their urine for 24 hours. Once a month, they will spend 24 hours in a metabolic suite to study their metabolism rate.
- Throughout stay, the food will be provided as part of the study.
- During the first and third month (75.2 degrees F) the participants will be allowed to leave the Metabolic Clinical Research unit during the weekends, while during the second and forth month (66.2 or 80.6 degrees F), the participants will be allowed to spend one weekend out of the Metabolic Clinical Research unit.
- Other tests, such as body scans, fat tissue samples, and imaging studies, will be performed as needed.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Nov 2012
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 17, 2012
CompletedStudy Start
First participant enrolled
November 17, 2012
CompletedFirst Posted
Study publicly available on registry
November 21, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 24, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
May 10, 2018
CompletedMay 14, 2018
May 10, 2018
1.6 years
November 17, 2012
May 11, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
To determine the inducibility and plasticity of brown adipose tissue activity by chronic mild cold exposure in healthy adults.
Secondary Outcomes (2)
Evaluate the metabolic sequelae of chronic mild cold exposure
Evaluate the mechanisms underlying cold-induced metabolic changes
Eligibility Criteria
You may qualify if:
- Male
- Between 18-40 years old
- Willing to participate and provide informed consent
You may not qualify if:
- Hypo- or hyper-thyroid (history or TSH greater than 5.0 or less than 0.4 milli-international units per liter)
- Blood pressure greater than 140/90 millimeters of mercury (19) or current antihypertensive therapy
- History of cardiovascular disease
- BMI less than or equal to 20 or greater than or equal to 25 kilogram per cubic meter
- Diabetes mellitus or impaired fasting glycemia (fasting serum glucose greater than 100 grams per liter).
- Hypercholesterolemia (serum greater than or equal to 240 levels grams per liter), hypertriglyceridemia (plasma greater than or equal to 220 levels grams per liter) and/or use of antilipemic therapy.
- Liver disease or ALT serum level greater than two fold the upper laboratory reference limit.
- Iron deficiency (Ferritin less than 40 nanograms per milliliter males) (20).
- Renal insufficiency or estimated creatinine clearance less than 50 milliliter per minute (MDRD equation).
- Claustrophobia.
- History of illicit drug or alcohol abuse within the last 5 years; current use of drugs (by history) or alcohol (CAGE greater than 3).
- Psychiatric conditions or behavior that would be incompatible with safe and successful participation in this study
- Current use of medications/dietary supplements/alternative therapies known to alter thyroid function.
- Current use of antiplatelet or anticoagulants.
- Allergy to lidocaine.
- +3 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
National Institutes of Health Clinical Center, 9000 Rockville Pike
Bethesda, Maryland, 20892, United States
Related Publications (4)
Ogden CL, Carroll MD, Kit BK, Flegal KM. Prevalence of obesity and trends in body mass index among US children and adolescents, 1999-2010. JAMA. 2012 Feb 1;307(5):483-90. doi: 10.1001/jama.2012.40. Epub 2012 Jan 17.
PMID: 22253364BACKGROUNDCowburn G, Hillsdon M, Hankey CR. Obesity management by life-style strategies. Br Med Bull. 1997;53(2):389-408. doi: 10.1093/oxfordjournals.bmb.a011619.
PMID: 9246842BACKGROUNDHankey CR. Session 3 (Joint with the British Dietetic Association): Management of obesity: Weight-loss interventions in the treatment of obesity. Proc Nutr Soc. 2010 Feb;69(1):34-8. doi: 10.1017/S0029665109991844. Epub 2009 Dec 15.
PMID: 20003637BACKGROUNDLee P, Smith S, Linderman J, Courville AB, Brychta RJ, Dieckmann W, Werner CD, Chen KY, Celi FS. Temperature-acclimated brown adipose tissue modulates insulin sensitivity in humans. Diabetes. 2014 Nov;63(11):3686-98. doi: 10.2337/db14-0513. Epub 2014 Jun 22.
PMID: 24954193DERIVED
Study Officials
- PRINCIPAL INVESTIGATOR
Kong Y Chen, Ph.D.
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- NIH
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 17, 2012
First Posted
November 21, 2012
Study Start
November 17, 2012
Primary Completion
June 24, 2014
Study Completion
May 10, 2018
Last Updated
May 14, 2018
Record last verified: 2018-05-10